Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer re...
Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy
About this item
Full title
Author / Creator
Publisher
Greece: D.A. Spandidos
Journal title
Language
English
Formats
Publication information
Publisher
Greece: D.A. Spandidos
Subjects
More information
Scope and Contents
Contents
A range of new treatment options has recently become available for patients with advanced metastatic castration-resistant prostate cancer (mCRPC). Androgen deprivation therapy (ADT) with luteinizing hormone-releasing hormone is continued when performing chemotherapy or androgen deprivation with new second-generation therapeutic agents such as enzal...
Alternative Titles
Full title
Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5244876
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5244876
Other Identifiers
ISSN
1792-1074
E-ISSN
1792-1082
DOI
10.3892/ol.2016.5392
